Neuron number in the entorhinal cortex and CA1 in preclinical alzheimer disease

Archives of Neurology

Volumn 58, Issue 9, 2001, Pages 1395-1402

  Price, Joseph L ^a   Ko, Andy I ^a   Wade, Marcus J ^a   Tsou, Sarah K ^a   McKeel, Daniel W ^a   Morris, John C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELL COUNT; CLINICAL ARTICLE; DEGENERATIVE DISEASE; DISEASE SEVERITY; ENTORHINAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; NERVE CELL; NEUROLOGIC DISEASE; PRIORITY JOURNAL;

EID: 0034849725     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.58.9.1395     Document Type: Article

References (45)

1. Very mild Alzheimer's disease: Informant-based clinical, psychometric, and pathological distinction from normal aging
2. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease
3. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease
4. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease
5. Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging
6. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease
7. Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease
8. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease
9. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons
10. Neuropsychological detection and characterization of preclinical Alzheimer's disease
11. The preclinical phase of Alzheimer disease: A 22-year prospective study of the Framingham cohort
12. The course of cognitive impairment in preclinical Alzheimer disease: 3- and 6-year follow-up of a population-based sample
13. Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease?
14. Mild cognitive impairment represents early-stage Alzheimer's disease
15. Absence of cognitive impairment or decline in preclinical Alzheimer's disease
16. Profound loss of layer II entorhinal cortex neurons distinguishes very mild Alzheimer's disease from nondemented aging
17. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E e4 allele
18. Regionally specific loss of neurons in the aging human hippocampus
19. Differences in the pattern of hippocampal neuronal loss in normal aging and Alzheimer's disease
20. Loss and atrophy of layer II entorhinal codex neurons in elderly people with mild cognitive impairment
21. The Clinical Dementia Rating (CDR): Current version and scoring rules
22. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype
23. Retrospective postmortem dementia assessment: Validation of a new clinical interview to assist neuropathological study
24. Diagnosis of Alzheimer's disease
25. Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older
26. Neuropathological stageing of Alzheimer-related changes
27. For the Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II: Standardization of the neuropathologic assessment of Alzheimer's disease
28. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease
29. Hippocampal formation
30. The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis
31. Total number of neurons in the layers of the human entorhinal cortex
32. Mild cognitive impairment: Clinical characterization and outcome
33. Total number of neurons in the layers of the human entorhinal cortex
34. A prospective study of cognitive function and onset of dementia in cognitively healthy elders
35. Frequency of stages of Alzheimer-related lesions in different age categories
36. "Preclinical" AD revisited: Neuropathology of cognitively normal older adults
37. Hippocampal volumes in cogonitively normal persons at genetic risk for Alzheimer's disease
38. Specific hippocampal volume reductions in individuals at risk for Atzheimer's disease
39. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in nondemented elderly predict decline to Alzheimer's disease
40. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease
41. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E
42. Patterns of brain activation in people at risk for Alzheimer's disease
43. Amnesia, memory and brain systems
44. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
45. Cell death or synaptic loss in Alzheimer disease